Evista Product Description
Evista is a non-hormonal agent, used to improve bone mineral density. The mechanism of Evista action lies in improvement of bone metabolism, and partially, in reduction of concentration of bad cholesterol (LDL) in the blood.
For treatment of postmenopausal osteoporosis, Evista pills are indicated and supported by changes in lifestyle. This non-hormonal drug can also be used for prophylaxis or development of bone diseases in women, predisposed for leanness, with unhealthy lifestyle, inadequate potassium intake and other risk factors. To treat osteoporosis and to restore the skeleton function, one Evista 60mg pill per day should be taken orally.
If you’ve missed a scheduled daily dose of Evista, it is better to take this drug on the next day. Do not take two tablets of Evista at the same time to make up for a missed dose.
Using Evista tablets in combination with fat-soluble vitamin D and calcium reduces the duration of prophylaxis or the treatment of postmenopausal osteoporosis.
Non-hormonal drug Evista should be stored in its original package at controlled ambient temperature up to 25ºC, in a dry place, protected from direct sunlight.
Evista Safety Information
A long-term application of Evista non-hormonal pills increases risks of circulatory disorders, caused by blood clot formation. Women with high risk factors for blood clot formation should take Evista with extra caution.
All materials about postmenopausal osteoporosis, published in the review of Evista, are provided as an information service only. This information should not be used as a replacement for personal healthcare from the orthopedist, traumatologist, or other licensed professional practitioner. The online pharmacy shall not be responsible for any consequences, resulted from misinterpretation of the information on Evista.
Evista Side Effects
Approximately 8% of the women, who participated in Evista clinical investigations, experienced symptoms of vasodilatation or leg cramps. The risks of these adverse events are usually minimized at long-term treatment with Evista. In rare cases, Evista may cause: headache, vertigo, neuralgia, fainting, flu syndrome, cough, fever, indigestion, vomiting, diarrhea, or venous thromboembolism. If Evista is used in combination with progestin hormone, it may increase the risk of abdominal pain, breast pain, releasing gas, hot flushes, infection, or vaginal bleeding.